Otsuka Pharmaceutical

Creating New Products for Better Health Worldwide

Avanir is a subsidiary of Otsuka America, Inc. (OAI), a holding company established in the United States in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd., a global healthcare company.

Otsuka's Business

Otsuka has been committed for almost five decades to researching, developing, manufacturing and marketing innovative products, with a focus on pharmaceutical products for the treatment of central nervous system (CNS) conditions, as well as nutraceutical products for the maintenance of everyday health.

In pharmaceuticals, Otsuka is a leader in the challenging area of mental health and has research programs on several under-addressed diseases, including tuberculosis, a significant global public health issue. These commitments illustrate how Otsuka is a “big venture” company at heart, applying a youthful spirit of creativity in everything it does.

As a total healthcare company, Otsuka Pharmaceutical will continue to focus on unfulfilled needs of patients and consumers on a global scale, creating creative, innovative products and new market categories in our efforts to contribute to the health and well-being of people everywhere.

Tatsuo Higuchi

President, Representative Director of Otsuka Holdings Co., Ltd

Otsuka's History

Otsuka has been on a journey of creativity and innovation for nearly 100 years. During this time, Otsuka has discovered and developed treatments for central nervous system disorders, cardiovascular diseases, nephrology diseases, digestive diseases, cancer, respiratory and dermatology conditions and provided a range of clinical, nutritional and diagnostic products. From its early beginnings in Japan, Otsuka has grown into a global business with an international network of 189 companies and more than 47,000 employees across Asia-Pacific, the Americas, India, Europe and the Middle East. It’s a story that all began in 1921.

Learn more about Otsuka’s therapeutic areas

Learn more about Otsuka’s businesses

Avanir's Pipeline

We’re always looking forward to the next step: Delivering hope through tangible solutions for patients suffering from CNS conditions.

See Our Progress

Our History

A passion and unwavering commitment to relieving the burdens of patients and their caregivers has transformed us into pioneers in the treatment of CNS conditions.

Learn More

Who We Are

Every day, we bring a singular focus to the research and development of groundbreaking pharmaceutical treatments for people with central nervous system (CNS) conditions.

Learn More

Leadership Team

We have a passion for patients, based on our own personal experiences. When combined with scientific ingenuity and a commitment to transparency, we offer real solutions to those we serve.

Learn More

MLR-AVN-US-0490-1220